DANIEL A. ARTUSI - 01 Jan 2022 Form 4 Insider Report for MAXLINEAR INC (MXL)

Role
Director
Signature
/s/ Connie Kwong, as Attorney-in-Fact
Issuer symbol
MXL
Transactions as of
01 Jan 2022
Net transactions value
$0
Form type
4
Filing time
04 Jan 2022, 16:41:54 UTC
Previous filing
16 Dec 2021
Next filing
10 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXL Common Stock Options Exercise $0 +6,545 +44% $0.000000 21,284 01 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXL Restricted Stock Units Options Exercise $0 -6,545 -100% $0.000000* 0 01 Jan 2022 Common Stock 6,545 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of MaxLinear, Inc. Common Stock.
F2 Subject to the Reporting Person's continuing as a Director (as defined in the 2010 Equity Incentive Plan) through such date, one hundred percent (100%) of the RSUs subject to the award will vest on the earlier to occur of May 1, 2020 or the date immediately preceding the 2020 annual meeting of stockholders. Reporting Person deferred delivery of shares of Common Stock issuable upon the vesting of RSUs on May 1, 2020. On January 1, 2022, the deferred shares of Common Stock were delivered to the Reporting Person.